Location History:
- New York, NY (US) (2014)
- Rego Park, NY (US) (2017)
Company Filing History:
Years Active: 2014-2017
Title: The Innovations of Ruijiang Song
Introduction
Ruijiang Song is a prominent inventor based in Rego Park, NY (US). He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapies for HIV prevention and treatment. With a total of 3 patents to his name, Song's work is at the forefront of scientific advancement.
Latest Patents
Among his latest patents are groundbreaking inventions such as "Glycan-modified anti-CD4 antibodies for HIV prevention and therapy." This patent discloses glycan-modified anti-CD4 monoclonal antibodies with N-linked glycans attached to the variable region. It also includes expression vectors and cell lines useful for the production of such antibodies, emphasizing their potential use in HIV prevention and therapy. Another notable patent is "Glycan-modified anti-CD4 antibody with improved HIV-1 neutralizing activity," which similarly focuses on the development of glycan-modified anti-CD4 monoclonal antibodies aimed at enhancing HIV-1 neutralizing activity.
Career Highlights
Ruijiang Song is affiliated with The Rockefeller University, where he conducts his research and develops his innovative therapies. His work has garnered attention in the scientific community, contributing to advancements in HIV treatment options.
Collaborations
Some of his notable coworkers include David D. Ho and David Joon Ho, who have collaborated with him on various research projects. Their combined expertise has furthered the understanding and development of effective therapies in the fight against HIV.
Conclusion
Ruijiang Song's contributions to the field of biomedical research are invaluable. His innovative patents and collaborations highlight his commitment to advancing HIV prevention and therapy. His work continues to inspire future research and development in this critical area of health.